Marcos Milla

Marcos Milla currently works at Lumen Bioscience, Inc., as Director, ImmunOs Therapeutics AG, as Director from 2022, Enlaza Therapeutics, Inc., as Director, Alentar Biosciences, Inc., as Director, and Samsara BioCapital LLC, as Venture Partner from 2021.
Dr. Milla also formerly worked at Roche Pharmaceuticals, Inc., as Director from 2005 to 2009, Janssen Pharmaceuticals, Inc., as Senior Director-Discovery Sciences from 2014 to 2016, Adaptive Biotechnologies Corp., as Head-Discovery from 2016 to 2017, and Synthorx, Inc., as Chief Scientific Officer from 2018 to 2020.
Dr. Milla received his undergraduate degree in 1990 from Universidad Peruana Cayetano Heredia and doctorate degree in 1990 from Saint Louis University School of Medicine.